Navigation Links
Is Prior Testing Necessary For Diagnosis And Treatment Of Fecal Incontinence (FI) ?

Fecal incontinence (FI), describes a condition in which there is involuntary discharge of bowel contents.// FI sufferers deal with significant quality of life issues and their condition often remains undiagnosed.

An article published in The American Journal of Gastroenterology highlights the ongoing debate over whether testing is necessary prior to diagnosis and treatment of patients with fecal incontinence (FI).

Dr. Satish S.C. Rao, co-author of the study believes that a balance between the two primary treatment methods; those based on testing and those based on empirical data, must be achieved. “Diagnostic testing for fecal incontinence may not be required in every patient, but its judicious use will provide an objective portrayal of the underlying mechanism(s) together with a more reliable diagnosis,” says Rao.

However, these tests are not widely available. There is lack of training and concerns with the standardization of tests and the interpretation of results. “An improvement in diagnostic testing and cognitive skills can only occur through a renaissance in our approach to the art and science of gastroenterology,” says Rao.



Source-Eurekalert
RI
'"/>




Page: 1

Related medicine news :

1. British MPs Say Prostate Cancer Receives Low Priority in the NHS
2. Misplaced Priorities in Medicaid Dispensation
3. FDA Accords Priority Review For Pediatric Crohns Disease Drug
4. Funds Pumped In To Reduce Waiting List of Priority Patients
5. Children Health Care To Be Given Priority
6. Games Event Rejects Prior Transplant Patient
7. Hypertension Not Given Priority during Treatment
8. Healthcare And Education Top Most Priority Of The Govt: Nitish
9. Unicef Appeals To Prioritize Children In Fight Against AIDs
10. Global Health Issues To Take Priority In The Current G8 Summit In Russia
11. Anxiety In Children Prior To Surgery Might Complicate Recovery
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/9/2016)... (PRWEB) , ... February 09, 2016 , ... ... Techniques.” The guide will ensure lab personnel have a basic understanding of the ... lab measurement protocols. Enhanced understanding will help them reduce waste and rework to ...
(Date:2/9/2016)... California (PRWEB) , ... February 09, 2016 , ... i2i ... one of the highest preliminary data vendors in the latest KLAS report, Population Health ... i2i has led the developing market for population health management (PHM). The latest ...
(Date:2/8/2016)... , ... February 08, 2016 , ... ... with BASF Human Nutrition into the Food & Beverage and ... been BASF’s channel partner throughout Canada and USA geographies east of the Rocky ...
(Date:2/8/2016)... ... February 08, 2016 , ... Brenton Engineering , powered ... and flow wrapped products at WestPack 2015, February 9-11, in Anaheim, California. This ... to semi-automatic or fully-automatic case packing with a small footprint, rugged, highly flexible, ...
(Date:2/8/2016)... ... 08, 2016 , ... Local insurance agency Dennis Fuller & ... has initiated a fundraiser for a two year old little girl named Bella, ... To support this beautiful child who is facing life’s journey without her loving ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... new report "Global Anti-Bacterial Drugs Market Assessment & Forecast: 2015 - ... the North America continued to lead global ... translated into revenues worth US$ 16,907.3 million. ... Asia-Pacific , Latin America , ... anti-bacterial market is inclined towards North America ...
(Date:2/8/2016)... -- Respiratory Devices - Medical Devices Pipeline Assessment, ... report, " Respiratory Devices - Medical Devices Pipeline ... Devices currently in pipeline stage. The report ... comparative analysis of the products at various stages ... in the pipeline product development. It also provides ...
(Date:2/8/2016)... and FAIRFIELD, N.J. , Feb. 8, ... Pharmaceuticals, Inc. (Medimetriks) today announced that they have entered ... commercialization rights for OPA-15406 in the U.S. and ... manufacturing rights.  OPA-15406 is a topical, non-steroidal phosphodiesterase IV ... --> --> In ...
Breaking Medicine Technology: